el

Elevance Health

ELV
NYSE
$379.13

Does Elevance Health have high-quality management?

CEO Gail Boudreaux brings deep managed care experience and has steered Elevance from a pure insurer toward an integrated health company. The CFO transition to Mark Kaye added disciplined financial stewardship.

Leadership has communicated a long‑term algorithm of at least high‑single‑ to low‑double‑digit adjusted EPS growth and continues to reinvest into care models and technology while balancing capital returns. Execution through 2025’s cost pressure appears measured, with guidance resets and reaffirmations consistent with controllables.